4.4 Article

Molecular modeling and crystal structure of ERK2-hypothemycin complexes

期刊

JOURNAL OF STRUCTURAL BIOLOGY
卷 164, 期 1, 页码 18-23

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.jsb.2008.05.002

关键词

hypothemycin; ERK2; resorcylic acid lactones; molecular modeling; crystal structure

向作者/读者索取更多资源

Resorcylic acid lactones containing a cis-enone-such as hypothemycin-are susceptible to Michael addition reactions and are potent and specific inhibitors of about 45 of the known Ser/Thr/Tyr protein kinases. These inhibitors bind reversibly, and then form a covalent adduct with a completely conserved cysteine in the ATP binding site of their target kinases. As a paradigm for the structures of the cis-enone resorcylic acid lactone complexes with this subset of kinases, we have modeled the structure of ERK2-hypothemycin reversible and covalent complexes using docking and extended molecular dynamics simulations. Subsequently, we determined the 2.5 angstrom resolution crystal structure of the complex that was in excellent accord with the modeled structure. The results were used to discuss structure-activity relationships, and provide a structural template for the development of irreversible inhibitors that complement the ATP binding site of kinases. (c) 2008 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs)

Pasquale Linciano, Rosaria Benedetti, Luca Pinzi, Fabiana Russo, Ugo Chianese, Claudia Sorbi, Lucia Altucci, Giulio Rastelli, Livio Brasili, Silvia Franchini

Summary: HDAC inhibitors play a significant role in cancer treatment, but their lack of selectivity is a major drawback. Researchers have explored novel linker chemotypes to achieve selective inhibition of different HDAC isoforms. Through in vitro tests and docking calculations, it was found that some candidates could selectively inhibit HDAC1 or HDAC6.

BIOORGANIC CHEMISTRY (2021)

Article Chemistry, Multidisciplinary

Prediction of activity and selectivity profiles of human Carbonic Anhydrase inhibitors using machine learning classification models

Annachiara Tinivella, Luca Pinzi, Giulio Rastelli

Summary: The development of selective inhibitors for human Carbonic Anhydrase isoforms IX and XII is essential for cancer drug research. Machine learning classification models trained on high confidence data from ChEMBL were used to predict ligand activity and selectivity profiles. The results outperformed classic models built with a priori activity thresholds.

JOURNAL OF CHEMINFORMATICS (2021)

Article Biochemistry & Molecular Biology

Antifungal Activity and DNA Topoisomerase Inhibition of Hydrolysable Tannins from Punica granatum L.

Virginia Brighenti, Ramona Iseppi, Luca Pinzi, Annamaria Mincuzzi, Antonio Ippolito, Patrizia Messi, Simona Marianna Sanzani, Giulio Rastelli, Federica Pellati

Summary: The study investigated the inhibition ability of pomegranate phenolic compounds on plant and human fungal pathogens, identifying topoisomerases I and II as potential biological targets of punicalagin. Results suggest that punicalagin is a valuable candidate for combating human fungal infections.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Dual Targeting Strategies on Histone Deacetylase 6 (HDAC6) and Heat Shock Protein 90 (Hsp90)

Davide Bonanni, Andrea Citarella, Davide Moi, Luca Pinzi, Elisa Bergamini, Giulio Rastelli

Summary: The design of multi-target drugs is a growing field in medicinal chemistry, especially for complex diseases like cancer. This review focuses on the interplay between HDAC6 and Hsp90, two important targets for multi-target drug design. Crystallographic structures of HDAC6 and Hsp90 complexes are extensively reviewed, providing useful guidelines for the design of dual inhibitors.

CURRENT MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Chemoinformatics Analyses of Tau Ligands Reveal Key Molecular Requirements for the Identification of Potential Drug Candidates against Tauopathies

Luca Pinzi, Annachiara Tinivella, Giulio Rastelli

Summary: The Tau protein is important in neuronal cells, but its abnormal aggregation can lead to Tauopathies. Current treatments to reduce Tau aggregation are lacking, and there is a need for effective compounds with specific structural guidance.

MOLECULES (2021)

Article Biochemistry & Molecular Biology

LigAdvisor: a versatile and user-friendly web-platform for drug design

Luca Pinzi, Annachiara Tinivella, Luca Gagliardelli, Domenico Beneventano, Giulio Rastelli

Summary: Despite available in silico drug design tools, results are often challenging to integrate or utilize fully; Multi-target ligand rational design and drug repurposing are gaining attention; Computational tools and data-driven approaches can reveal new drug discovery opportunities, and LigAdvisor integrates various database information to facilitate drug discovery tasks.

NUCLEIC ACIDS RESEARCH (2021)

Article Chemistry, Medicinal

Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B

Luca G. Iacovino, Luca Pinzi, Giorgio Facchetti, Beatrice Bortolini, Michael S. Christodoulou, Claudia Binda, Giulio Rastelli, Isabella Rimoldi, Daniele Passarella, Maria Luisa Di Paolo, Lisa Dalla Via

Summary: A library of monosubstituted chalcones with electron-donating and electron-withdrawing groups on aromatic rings was selected for evaluation. Compounds 13 and 14 were found to inhibit MAO-B and may be worth considering as novel MAO-B-selective inhibitors for neurodegenerative disease treatment.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

Review Chemistry, Multidisciplinary

Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications

Andrea Citarella, Davide Moi, Luca Pinzi, Davide Bonanni, Giulio Rastelli

Summary: The hydroxamic acid (HA) moiety has gained notoriety in synthetic medicinal chemistry since the approval of three HDAC inhibitors as anticancer drugs. HAs are known for their ability to chelate metal ions, particularly Fe(III) and Zn(II), making them attractive metal binding groups with wide applications as metalloenzymes inhibitors. This review discusses the physicochemical characteristics of HAs, methods for their introduction into organic substrates, and their uses in medicinal chemistry.

ACS OMEGA (2021)

Article Chemistry, Medicinal

Design, synthesis, biological evaluation and crystal structure determination of dual modulators of carbonic anhydrases and estrogen receptors

Annachiara Tinivella, Jerome C. Nwachukwu, Andrea Angeli, Francesca Foschi, Anna Laura Benatti, Luca Pinzi, Tina Izard, Marta Ferraroni, Rangarajan Erumbi, Michael S. Christodoulou, Daniele Passarella, Claudiu T. Supuran, Kendall W. Nettles, Giulio Rastelli

Summary: In this study, a ligand-based and structure-based multi-target repurposing strategy was used to investigate hexahydrocyclopenta[c]quinoline compounds. Human Carbonic Anhydrases (hCA) and Estrogen Receptors (ER) were identified as top candidates for dual modulation. Two new compounds were designed and synthesized, which directly modulate the activities of both hCA and ER. These compounds showed potent inhibition of cancer cell proliferation and selectivity for different cell types. This study lays the foundation for optimizing the multi-target activity of hCA and ER.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFR

Francesca Foschi, Annachiara Tinivella, Valentina Crippa, Luca Pinzi, Luca Mologni, Daniele Passarella, Giulio Rastelli

Summary: This study reported the design and synthesis of novel anticancer drugs targeting EGFR protein kinase. By studying analogues of a previously identified hit compound, two compounds with improved activity against double mutant EGFR and interesting anti-proliferative activity against NSCLC cancer cells were discovered. These newly discovered compounds represent promising starting points for further optimization.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

Development of machine learning classifiers to predict compound activity on prostate cancer cell lines

Davide Bonanni, Luca Pinzi, Giulio Rastelli

Summary: Prostate cancer is the most common type of cancer in men and effective therapeutic answers are urgently needed. By developing machine learning models, researchers were able to predict the activity of potential therapeutics for prostate cancer, achieving prediction performances with MCC values above 0.60 for PC-3 and DU-145 cells.

JOURNAL OF CHEMINFORMATICS (2022)

Article Biochemistry & Molecular Biology

Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing

Leonardo Bernal, Luca Pinzi, Giulio Rastelli

Summary: Prostate cancer (PC) is a common cancer in males with poor prognosis in advanced stages. Current therapeutic options are limited and not very effective. This study analyzed compounds with anti-proliferative activity on PC cell lines and identified potential drugs for repurposing against PC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status

Luca Pinzi, Nicolo Bisi, Claudia Sorbi, Silvia Franchini, Nicolo Tonali, Giulio Rastelli

Summary: Tau is a protein with large structural portions that undergo extended conformational changes. Accumulation of Tau protein into toxic aggregates in neuronal cells leads to severe tauopathies. Recent research advancements have provided a better understanding of Tau structures and their implications in different tauopathies. This review presents an up-to-date overview of Tau structures reported in the Protein Data Bank, focusing on the connections between structural features, tauopathies, crystallization conditions, and sample types. The information presented highlights interesting links that could aid in the design of compounds to modulate Tau aggregation.

MOLECULES (2023)

Article Chemistry, Multidisciplinary

Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring

Davide Moi, Andrea Citarella, Davide Bonanni, Luca Pinzi, Daniele Passarella, Alessandra Silvani, Clelia Giannini, Giulio Rastelli

Summary: In this study, two potent and selective HDAC6 inhibitors were obtained through chemoinformatic analysis. The newly discovered aminotriazole-based compounds showed higher inhibitory activity and have the potential to be optimized as anticancer compounds.

RSC ADVANCES (2022)

Article Biochemistry & Molecular Biology

Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group

Pasquale Linciano, Luca Pinzi, Silvia Belluti, Ugo Chianese, Rosaria Benedetti, Davide Moi, Lucia Altucci, Silvia Franchini, Carol Imbriano, Claudia Sorbi, Giulio Rastelli

Summary: Histone deacetylase 6 (HDAC6) inhibitors based on a novel 3-hydroxy-isoxazole ZBG were synthesized and tested for their efficacy. Some compounds showed potent inhibition of HDAC6 with the best candidate reaching an IC50 of 700 nM, making them attractive for further studies. Additionally, the most active inhibitors were investigated for their effects on histone H3 and alpha-tubulin acetylation levels, as well as anti-proliferative activity in DU145 cells.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)

暂无数据